“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories
暂无分享,去创建一个
Declan T. Barry | R. Marcus | M. Beitel | Lindsay M. S. Oberleitner | Lynn M. Madden | E. Thompson | David E. Oberleitner | Anthony Eller | Marina Gaeta Gazzola | K. Hoffman
[1] P. Friedmann,et al. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. , 2022, The International journal on drug policy.
[2] J. Rich,et al. Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration , 2022, Journal of addiction medicine.
[3] P. Friedmann,et al. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. , 2022, The International journal on drug policy.
[4] J. Rehm,et al. Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada , 2022, International journal of qualitative studies on health and well-being.
[5] James A. Evans,et al. Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care. , 2022, Drug and alcohol dependence.
[6] Christy K. Scott,et al. Scoping review of interventions to link individuals to substance use services at discharge from jail. , 2022, Journal of substance abuse treatment.
[7] J. Rich,et al. Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting. , 2021, Journal of addiction medicine.
[8] R. Heimer,et al. Post-incarceration outcomes for individuals who continued methadone treatment while in Connecticut jails, 2014-2018. , 2021, Drug and alcohol dependence.
[9] Rebecca J. Shlafer,et al. Physicians’ perspectives on continuity of care for patients involved in the criminal justice system: A qualitative study , 2021, PloS one.
[10] Christy A. Visher,et al. "I've just never done that:" The influence of transitional anxiety on post-incarceration reentry and reintegration experiences among veterans. , 2021, Health & social care in the community.
[11] M. Compton,et al. Criminal Legal Involvement: A Cause and Consequence of Social Determinants of Health. , 2021, Psychiatric services.
[12] Alex H. S. Harris,et al. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. , 2021, Journal of substance abuse treatment.
[13] R. Schwartz,et al. Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services. , 2021, Journal of substance abuse treatment.
[14] D. Fiellin,et al. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. , 2021, Journal of Substance Abuse Treatment.
[15] Lori J. Ducharme,et al. Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN). , 2021, Journal of substance abuse treatment.
[16] M. Ekstrand,et al. Transitioning into the Community: Perceptions of Barriers and Facilitators Experienced By Formerly Incarcerated, Homeless Women During Reentry—A Qualitative Study , 2021, Community Mental Health Journal.
[17] A. Slaunwhite,et al. Risk of Overdose-Related Death for People with a History of Incarceration. , 2020, Addiction.
[18] Rosemarie A. Martin,et al. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study. , 2020, The International journal on drug policy.
[19] F. Kouyoumdjian,et al. “When you first walk out the gates…where do [you] go?”: Barriers and opportunities to achieving continuity of health care at the time of release from a provincial jail in Ontario , 2020, PloS one.
[20] Luke Muentner,et al. A Qualitative Exploration of Reentry Service Needs: The Case of Fathers Returning From Prison. , 2019, Child & family social work.
[21] S. Bonato,et al. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review , 2019, PLoS medicine.
[22] Kim A. Hoffman,et al. Opioid use disorder and treatment: challenges and opportunities , 2019, BMC Health Services Research.
[23] B. Tofighi,et al. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail , 2019, Addiction Science & Clinical Practice.
[24] B. Western,et al. Drug use in the year after prison. , 2019, Social science & medicine.
[25] D. McInnes,et al. A conceptual model for understanding post-release opioid-related overdose risk , 2019, Addiction Science & Clinical Practice.
[26] Adam Chamberlain,et al. Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study , 2019, Addiction Science & Clinical Practice.
[27] D. Pinals,et al. Evaluating the implementation of a prisoner re-entry initiative for individuals with opioid use and mental health disorders: Application of the consolidated framework for implementation research in a cross-system initiative. , 2019, Journal of substance abuse treatment.
[28] A. Leshner,et al. Medications for Opioid Use Disorder Save Lives , 2019 .
[29] Robyn L. Hacker,et al. Reentry interventions that address substance use: A systematic review. , 2020, Psychological services.
[30] S. Marshall,et al. Opioid Overdose Mortality Among Former North Carolina Inmates: 2000-2015 , 2018, American journal of public health.
[31] Declan T. Barry,et al. An investigation of an open‐access model for scaling up methadone maintenance treatment , 2018, Addiction.
[32] S. Ward,et al. Systematic review of qualitative evaluations of reentry programs addressing problematic drug use and mental health disorders amongst people transitioning from prison to communities , 2018, Health & Justice.
[33] S. Ward,et al. Systematic review of qualitative evaluations of reentry programs addressing problematic drug use and mental health disorders amongst people transitioning from prison to communities , 2018, Health & justice.
[34] C. Lindquist,et al. Partnership after prison: Couple relationships during reentry , 2018 .
[35] C. Lindquist,et al. “Always having hope”: Father–child relationships after reentry from prison , 2018 .
[36] S. Bird,et al. Methods for delivering the UK's multi‐centre prison‐based naloxone‐on‐release pilot randomised trial (N‐ALIVE): Europe's largest prison‐based randomised controlled trial , 2017, Drug and alcohol review.
[37] K. Feder,et al. Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine. , 2017, Health affairs.
[38] J. Strang,et al. High risk of overdose death following release from prison: variations in mortality during a 15‐year observation period , 2017, Addiction.
[39] Ashley Wennerstrom,et al. Bringing it all back home: Understanding the medical difficulties encountered by newly released prisoners in New Orleans, Louisiana – a qualitative study , 2017, Health & social care in the community.
[40] S. Bird,et al. Randomized controlled pilot trial of naloxone‐on‐release to prevent post‐prison opioid overdose deaths , 2016, Addiction.
[41] J. M. Miller,et al. Reentry programming for opioid and opiate involved female offenders: Findings from a mixed methods evaluation , 2016 .
[42] Shane R Mueller,et al. Clinical risk factors for death after release from prison in Washington State: a nested case-control study. , 2016, Addiction.
[43] T. J. Early,et al. Mental Health and Substance Abuse Service Engagement by Men and Women During Community Reentry Following Incarceration , 2016, Administration and Policy in Mental Health and Mental Health Services Research.
[44] K. Kampman,et al. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use , 2015, Journal of addiction medicine.
[45] Andrea Cantora. Navigating the job search after incarceration: the experiences of work-release participants , 2015 .
[46] C. Cunningham,et al. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder , 2015, Addiction Science & Clinical Practice.
[47] M. Welsh,et al. Rendering Invisible Punishments Visible , 2014 .
[48] Christy A. Visher,et al. Reentry Challenges Facing Women with Mental Health Problems , 2014, Women & health.
[49] Bridget C. O’Brien,et al. Standards for Reporting Qualitative Research: A Synthesis of Recommendations , 2014, Academic medicine : journal of the Association of American Medical Colleges.
[50] Shane R. Mueller,et al. Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009 , 2013, Annals of Internal Medicine.
[51] J. Steiner,et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors , 2012, Addiction Science & Clinical Practice.
[52] J. Kutner,et al. "From the prison door right to the sidewalk, everything went downhill," a qualitative study of the health experiences of recently released inmates. , 2011, International journal of law and psychiatry.
[53] J. Rich,et al. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. , 2009, Drug and alcohol dependence.
[54] N. Freudenberg,et al. Nowhere to go: How stigma limits the options of female drug users after release from jail , 2009, Substance abuse treatment, prevention, and policy.
[55] J. Elmore,et al. Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.
[56] Robert C. Davis,et al. GOOD INTENTIONS MEET HARD REALITIES: AN EVALUATION OF THE PROJECT GREENLIGHT REENTRY PROGRAM , 2006 .
[57] V. Braun,et al. Using thematic analysis in psychology , 2006 .
[58] Cheryl L Cooke. Going Home: Formerly Incarcerated African American Men Return to Families and Communities , 2005, Journal of family nursing.
[59] J. Petersilia,et al. When Prisoners Come Home: Parole and Prisoner Reentry , 2009 .
[60] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[61] P. O’Brien,et al. “Just like Baking a Cake”: Women Describe the Necessary Ingredients for Successful Reentry after Incarceration , 2001 .
[62] H. Hart. I: Justice , 1953, Philosophy.